ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,172Medicare Part D Prescriptions Filled, Including Refills

Rank: 98 out of 2680

$765K Total Retail Price of All Prescriptions

Rank: 122 out of 2680

494 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 494 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 494 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

4% of this provider’s 8,398 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
AMLODIPINE BESYLATE 458 333 1 3
MIRTAZAPINE 432 375 2 48
SIMVASTATIN 359 291 3 1
LISINOPRIL 303 254 4 5
FUROSEMIDE 280 190 5 7
LEVOTHYROXINE SODIUM 279 214 6 4
OMEPRAZOLE 245 204 7 2
METOPROLOL TARTRATE 243 200 8 8
RISPERIDONE 234 175 9 67
DIVALPROEX SODIUM 222 134 10 90
HALOPERIDOL 207 119 11 153
METFORMIN HCL 202 116 12 6
ZOLPIDEM TARTRATE 198 102 13 17
TRIHEXYPHENIDYL HCL 180 141 R 14 395
TAMSULOSIN HCL 172 150 15 25
WARFARIN SODIUM 161 116 16 12
DONEPEZIL HCL 157 153 17 28
BENZTROPINE MESYLATE 154 110 R 18 193
GABAPENTIN 148 92 19 21
LEVETIRACETAM 145 89 20 94
HYDROCHLOROTHIAZIDE 136 103 21 9
CITALOPRAM HBR 134 84 22 22
QUETIAPINE FUMARATE 120 88 23 72
ENALAPRIL MALEATE 118 87 24 24
TRAZODONE HCL 114 91 25 60
NAMENDA 112 98 26 43
ENDOCET 110 34 S2 27 180
NEXIUM 103 52 28 19
VALPROIC ACID 102 82 29 221
HYDROCODONE-ACETAMINOPHEN 99 27 S3 30 13
LACTULOSE 88 56 31 100
ATENOLOL 87 53 32 14
OLANZAPINE 86 66 33 128
IBUPROFEN 82 44 34 63
SPIRIVA 81 65 35 36
RANITIDINE HCL 76 55 36 35
CLONIDINE HCL 75 38 37 84
PROAIR HFA 73 44 38 52
CARVEDILOL 73 69 38 27
NUEDEXTA 73 62 38 444
ATORVASTATIN CALCIUM 71 39 41 10
LANTUS 71 39 41 70
CIPROFLOXACIN HCL 70 37 43 85
CRESTOR 68 36 44 15
NOVOLIN R 68 61 44 210
DIOVAN 67 47 46 26
ALBUTEROL SULFATE 65 50 47 97
HALOPERIDOL LACTATE 65 43 47 503
AMOX TR-POTASSIUM CLAVULANATE 64 41 49 145
CARBIDOPA-LEVODOPA 63 48 50 88
VENTOLIN HFA 63 36 50 61
FINASTERIDE 57 57 52 80
MECLIZINE HCL 51 23 53 105
HYDRALAZINE HCL 50 25 54 99
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 12, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.